{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T17:25:28Z","timestamp":1790011528446,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T00:00:00Z","timestamp":1772236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":38,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"DOI":"10.1186\/s41927-026-00628-w","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T09:34:45Z","timestamp":1772271285000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Weight loss ameliorates symptoms of osteoarthritis and is correlated with alterations in soluble bone and cartilage markers: an analysis of patient-reported outcomes and biomarkers"],"prefix":"10.1186","volume":"10","author":[{"given":"Anne-Christine","family":"Bay-Jensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peder","family":"Frederiksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asger","family":"Bihlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thudium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,28]]},"reference":[{"key":"628_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1016\/j.joca.2018.11.002","volume":"27","author":"VB Kraus","year":"2019","unstructured":"Kraus VB, Simon LS, Katz JN, Neogi T, Hunter D, Guermazi A, et al. Proposed study designs for approval based on a surrogate endpoint and a post-marketing confirmatory study under FDA\u2019s accelerated approval regulations for disease modifying osteoarthritis drugs. Osteoarthr Cartil. Elsevier Ltd. 2019;27:571\u201379. https:\/\/doi.org\/10.1016\/j.joca.2018.11.002.","journal-title":"Osteoarthr Cartil. Elsevier Ltd"},{"key":"628_CR2","doi-asserted-by":"publisher","first-page":"100262","DOI":"10.1016\/J.OCARTO.2022.100262","volume":"4","author":"MA Karsdal","year":"2022","unstructured":"Karsdal MA, Tambiah J, Hochberg MC, Ladel C, Bay-Jensen AC, Arendt-Nielsen L, et al. Reflections from the 2021 OARSI clinical trial symposium: considerations for understanding biomarker assessments in osteoarthritis drug development - should future studies focus on disease activity, rather than status? Osteoarthr Cartil Open. Elsevier. 2022;4:100262. https:\/\/doi.org\/10.1016\/J.OCARTO.2022.100262.","journal-title":"Osteoarthr Cartil Open. Elsevier"},{"key":"628_CR3","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1001\/jama.2019.14735","volume":"322","author":"MC Hochberg","year":"2019","unstructured":"Hochberg MC, Guermazi A, Guehring H, Aydemir A, Wax S, Fleuranceau-Morel P, et al. Effect of intra-articular sprifermin vs placebo on femorotibial joint cartilage thickness in patients with osteoarthritis: the FORWARD randomized clinical trial. JAMA. 2019;322:1360\u201370. https:\/\/doi.org\/10.1001\/jama.2019.14735.","journal-title":"JAMA"},{"key":"628_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.joca.2013.10.018","volume":"22","author":"MA Karsdal","year":"2014","unstructured":"Karsdal MA, Christiansen C, Ladel C, Henriksen K, Kraus VB, Bay-Jensen AC. Osteoarthritis - a case for personalized health care? Osteoarthr Cartil. 2014;22:7\u201316. https:\/\/doi.org\/10.1016\/j.joca.2013.10.018.","journal-title":"Osteoarthr Cartil"},{"key":"628_CR5","doi-asserted-by":"publisher","unstructured":"Henriques J, Berenbaum F, Mobasheri A. Obesity-induced fibrosis in osteoarthritis: pathogenesis, consequences and novel therapeutic opportunities. In: Osteoarthr Cartil Open [Internet]. Elsevier Ltd; 2024;6:100511. cited 2025 Sep 5. https:\/\/doi.org\/10.1016\/j.ocarto.2024.100511.","DOI":"10.1016\/j.ocarto.2024.100511"},{"key":"628_CR6","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1080\/14656566.2022.2104636","volume-title":"A narrative review of anti-obesity medications for obese patients with osteoarthritis. Expert Opin Pharmacother","author":"WM Oo","year":"2022","unstructured":"Oo WM, Mobasheri A, Hunter DJ. A narrative review of anti-obesity medications for obese patients with osteoarthritis. Expert Opin Pharmacother. Vol. 23. Taylor and Francis Ltd; 2022. pp. 1381\u201395. https:\/\/doi.org\/10.1080\/14656566.2022.2104636."},{"key":"628_CR7","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/S0140-6736(21)01919-X","volume":"399","author":"I Lingvay","year":"2022","unstructured":"Lingvay I, Sumithran P, Cohen R V, le Roux CW. Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation. Lancet. 2022;399:394\u2013405. https:\/\/doi.org\/10.1016\/S0140-6736(21)01919-X.","journal-title":"Lancet"},{"key":"628_CR8","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","volume":"373","author":"S MacMahon","year":"2009","unstructured":"MacMahon S, Baigent C, Duffy S, Rodgers A, Tominaga S, Chambless L, et al. Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. The Lancet. Elsevier Ltd. 2009;373:1083\u201396. https:\/\/doi.org\/10.1016\/S0140-6736(09)60318-4.","journal-title":"The Lancet. Elsevier Ltd"},{"key":"628_CR9","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/EJHF.2403","volume":"24","author":"AM Jackson","year":"2022","unstructured":"Jackson AM, R\u00f8rth R, Liu J, Kristensen SL, Anand IS, Claggett BL, et al. Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2022;24:497\u2013509. https:\/\/doi.org\/10.1002\/EJHF.2403.","journal-title":"Eur J Heart Fail"},{"key":"628_CR10","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1093\/RHEUMATOLOGY\/KEX145","volume-title":"Long-term effects of a lifestyle intervention and oral glucosamine sulphate in primary care on incident knee OA in overweight women","author":"de Vos Bc","year":"2017","unstructured":"de Vos Bc, Landsmeer MLA, van Middelkoop M, Oei EHG, Krul M, Bierma-Zeinstra SMA, et al. Long-term effects of a lifestyle intervention and oral glucosamine sulphate in primary care on incident knee OA in overweight women. Vol. 56. Rheumatology (Oxford). Rheumatology (Oxford); 2017. pp. 1326\u201334. https:\/\/doi.org\/10.1093\/RHEUMATOLOGY\/KEX145."},{"key":"628_CR11","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/S12889-024-17682-Z","volume-title":"Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study","author":"S Zhang","year":"2024","unstructured":"Zhang S, Wang D, Zhao J, Zhao H, Xie P, Zheng L, et al. Metabolic syndrome increases osteoarthritis risk: findings from the UK Biobank prospective cohort study. BMC Public Health. BMC Public Health; 2024. p. 24. https:\/\/doi.org\/10.1186\/S12889-024-17682-Z."},{"key":"628_CR12","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1016\/j.joca.2017.07.015","volume-title":"Effects of dietary weight loss with and without exercise on interstitial matrix turnover and tissue inflammation biomarkers in adults with knee osteoarthritis: the intensive diet and exercise for Arthritis trial (IDEA)","author":"RF Loeser","year":"2017","unstructured":"Loeser RF, Beavers DP, Bay-Jensen AC, Karsdal MA, Nicklas BJ, Guermazi A, et al. Effects of dietary weight loss with and without exercise on interstitial matrix turnover and tissue inflammation biomarkers in adults with knee osteoarthritis: the intensive diet and exercise for Arthritis trial (IDEA). Vol. 25. Osteoarthritis Cartilage. Elsevier Ltd; 2017. pp. 1822\u201328. https:\/\/doi.org\/10.1016\/j.joca.2017.07.015."},{"key":"628_CR13","doi-asserted-by":"publisher","first-page":"509","DOI":"10.7326\/M20-0527","volume":"173","author":"M Schieker","year":"2020","unstructured":"Schieker M, Conaghan PG, Mindeholm L, Praestgaard J, Solomon DH, Scotti C, et al. Effects of interleukin-1\u03b2 inhibition on incident Hip and knee replacement: exploratory analyses from a randomized, Double-Blind, placebo-controlled trial. Ann Intern Med. 2020;173:509\u201315. https:\/\/doi.org\/10.7326\/M20-0527.","journal-title":"Ann Intern Med"},{"key":"628_CR14","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1007\/s11695-015-1845-x","volume":"26","author":"I Birn","year":"2016","unstructured":"Birn I, Mechlenburg I, Liljens\u00f8e A, Soballe K, Larsen JF. The association between preoperative symptoms of obesity in knee and Hip joints and the change in quality of Life after laparoscopic Roux-en-Y gastric bypass. OBES Surg. 2016;26:950\u201356. https:\/\/doi.org\/10.1007\/s11695-015-1845-x.","journal-title":"OBES Surg"},{"key":"628_CR15","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1093\/ajcn\/nqaa328","volume":"113","author":"H Gudbergsen","year":"2021","unstructured":"Gudbergsen H, Overgaard A, Henriksen M, W\u00e6hrens EE, Bliddal H, Christensen R, et al. Liraglutide after diet-induced weight loss for pain and weight control in knee osteoarthritis: a randomized controlled trial. Am J Clin Nutr. 2021;113:314\u201323. https:\/\/doi.org\/10.1093\/ajcn\/nqaa328.","journal-title":"Am J Clin Nutr"},{"key":"628_CR16","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.jot.2022.02.001","volume":"32","author":"C Meurot","year":"2022","unstructured":"Meurot C, Jacques C, Martin C, Sudre L, Breton J, Rattenbach R, et al. Targeting the GLP-1\/GLP-1R axis to treat osteoarthritis: a new opportunity? J Orthop Translat. 2022;32:121\u201329. https:\/\/doi.org\/10.1016\/j.jot.2022.02.001.","journal-title":"J Orthop Translat"},{"key":"628_CR17","unstructured":"Schindler M. Capital markets day 2024, obesity care. 2024;p. 20. https:\/\/www.novonordisk.com\/investors\/capital-markets-day-2024.html."},{"key":"628_CR18","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.bone.2019.07.014","volume":"127","author":"IK Blom-H\u00f8gest\u00f8l","year":"2019","unstructured":"Blom-H\u00f8gest\u00f8l IK, Hewitt S, Chahal-Kummen M, Brunborg C, Gulseth HL, Kristinsson JA, et al. Bone metabolism, bone mineral density and low-energy fractures 10 years after Roux-en-Y gastric bypass. Bone. 2019;127:436\u201345. https:\/\/doi.org\/10.1016\/j.bone.2019.07.014.","journal-title":"Bone"},{"key":"628_CR19","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1016\/j.soard.2019.06.028","volume":"15","author":"AB Gondal","year":"2019","unstructured":"Gondal AB, Hsu CH, Zeeshan M, Hamidi M, Joseph B, Ghaderi I. A frailty index and the impact of frailty on postoperative outcomes in older patients after bariatric surgery. Surg Obes Relat Dis. 2019;15:1582\u201388. https:\/\/doi.org\/10.1016\/j.soard.2019.06.028.","journal-title":"Surg Obes Relat Dis"},{"key":"628_CR20","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1002\/art.1780361205","volume-title":"Bone mineral density and knee osteoarthritis in elderly men and women. The Framingham study","author":"MT Hannan","year":"1993","unstructured":"Hannan MT, Anderson JJ, Zhang Y, Levy D, Felson DT. Bone mineral density and knee osteoarthritis in elderly men and women. The Framingham study. Massachusetts: Arthritis Rheum. Boston University Multipurpose Arthritis Center, Harvard Medical School. 1993;36:p. 1671\u201380. https:\/\/doi.org\/10.1002\/art.1780361205."},{"key":"628_CR21","first-page":"1032","volume":"27","author":"Y Zhang","year":"2000","unstructured":"Zhang Y, Hannan MT, Chaisson CE, McAlindon TE, Evans SR, Aliabadi P, et al. Bone mineral density and risk of incident and progressive radiographic knee osteoarthritis in women: the Framingham study. J Educ Chang Rheumatol. 2000;27:1032\u201337.","journal-title":"J Educ Chang Rheumatol"},{"key":"628_CR22","first-page":"R18","volume-title":"Effects on osteoclast and osteoblast activities in cultured mouse calvarial bones by synovial fluids from patients with a loose joint prosthesis and from osteoarthritis patients. Arthritis Res Ther","author":"MK Andersson","year":"2007","unstructured":"Andersson MK, Lundberg P, Ohlin A, Perry MJ, Lie A, Stark A, et al. Department of Orthopaedic Surgery, Karolinska Hospital, Karolinska Institute, 171 76, Stockholm, Sweden. martin.andersson.502@student.ki.se. Effects on osteoclast and osteoblast activities in cultured mouse calvarial bones by synovial fluids from patients with a loose joint prosthesis and from osteoarthritis patients. Arthritis Res Ther. Vol. 9. 2007. p. R18."},{"key":"628_CR23","doi-asserted-by":"publisher","first-page":"8303","DOI":"10.3390\/IJMS23158303","volume":"23","author":"A Pi\u00f1ar-Gutierrez","year":"2022","unstructured":"Pi\u00f1ar-Gutierrez A, Garc\u00eda-Fontana C, Garc\u00eda-Fontana B, Mu\u00f1oz-Torres M. Obesity and Bone Health: a Complex relationship. Int J Mol Sci. 2022;23:8303. https:\/\/doi.org\/10.3390\/IJMS23158303.","journal-title":"Int J Mol Sci"},{"key":"628_CR24","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/14737159.2024.2315282","volume":"24","author":"MT Hannani","year":"2024","unstructured":"Hannani MT, Thudium CS, Karsdal MA, Ladel C, Mobasheri A, Uebelhoer M, et al. From biochemical markers to molecular endotypes of osteoarthritis: a review on validated biomarkers. Expert Rev Mol Diagn [Internet]. 2024;24:23\u201338. https:\/\/doi.org\/10.1080\/14737159.2024.2315282. cited 2025 Jan 23.","journal-title":"Expert Rev Mol Diagn"},{"key":"628_CR25","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1136\/annrheumdis-2016-209252","volume":"76","author":"VB Kraus","year":"2017","unstructured":"Kraus VB, Collins JE, Hargrove D, Losina E, Nevitt M, Katz JN, et al. Predictive validity of biochemical biomarkers in knee osteoarthritis: data from the FNIH OA biomarkers Consortium. Ann Rheum Dis. 2017;76:186\u201395. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209252.","journal-title":"Ann Rheum Dis"},{"key":"628_CR26","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.joca.2014.12.019","volume-title":"Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials. Osteoarthritis cartilage","author":"MAA Karsdal","year":"2015","unstructured":"Karsdal MAA, Byrjalsen I, Alexandersen P, Bihlet A, Andersen JRR, Riis BJJ, et al. Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials. Osteoarthritis cartilage. W.B. Saunders Ltd; 2015;23:p. 532\u201343. https:\/\/doi.org\/10.1016\/j.joca.2014.12.019."},{"key":"628_CR27","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/annrheumdis-2013-203989","volume":"74","author":"J-P Pelletier","year":"2015","unstructured":"Pelletier J-P, Roubille C, Raynauld J-P, Abram F, Dorais M, Delorme P, et al. Disease-modifying effect of strontium ranelate in a subset of patients from the phase III knee osteoarthritis study SEKOIA using quantitative MRI: reduction in bone marrow lesions protects against cartilage loss. Ann Rheum Dis. 2015;74:422\u201329. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203989.","journal-title":"Ann Rheum Dis"},{"key":"628_CR28","first-page":"R625","volume-title":"Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther","author":"TD Spector","year":"2005","unstructured":"Spector TD, Conaghan PG, Buckland-Wright JC, Garnero P, Cline GA, Beary JF, et al. Effect of risedronate on joint structure and symptoms of knee osteoarthritis: results of the BRISK randomized, controlled trial [ISRCTN01928173]. Arthritis Res Ther. Vol. 7. Twin Research & Genetic Epidemiology Unit, St Thomas\u2019 Hospital, London, UK. tim.spector@kcl.ac.uk; 2005. p. R625\u201333."},{"key":"628_CR29","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1136\/ANNRHEUMDIS-2013-204111","volume":"73","author":"MA Karsdal","year":"2014","unstructured":"Karsdal MA, Bay-Jensen AC, Lories RJ, Abramson S, Spector T, Pastoureau P, et al. The coupling of bone and cartilage turnover in osteoarthritis: opportunities for bone antiresorptives and anabolics as potential treatments? Ann Rheum Dis. Ann Rheum Dis. 2014;73:336\u201348. https:\/\/doi.org\/10.1136\/ANNRHEUMDIS-2013-204111.","journal-title":"Ann Rheum Dis"},{"key":"628_CR30","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.joca.2014.12.019","volume":"23","author":"MA Karsdal","year":"2015","unstructured":"Karsdal MA, Byrjalsen I, Alexandersen P, Bihlet A, Andersen JR, Riis BJ, et al. Treatment of symptomatic knee osteoarthritis with oral salmon calcitonin: results from two phase 3 trials. Osteoarthr Cartil. 2015;23:532\u201343. https:\/\/doi.org\/10.1016\/j.joca.2014.12.019.","journal-title":"Osteoarthr Cartil"},{"key":"628_CR31","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1111\/OBR.12686","volume":"19","author":"L Cooper","year":"2018","unstructured":"Cooper L, Ryan CG, Ells LJ, Hamilton S, Atkinson G, Cooper K, et al. Weight loss interventions for adults with overweight\/obesity and chronic musculoskeletal pain: a mixed methods systematic review. Obes Rev. 2018;19:989\u20131007. https:\/\/doi.org\/10.1111\/OBR.12686.","journal-title":"Obes Rev. Obes Rev"},{"key":"628_CR32","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1002\/acr.23608","volume":"70","author":"SP Messier","year":"2018","unstructured":"Messier SP, Resnik AE, Beavers DP, Mihalko SL, Miller GD, Nicklas BJ, et al. Intentional weight loss in overweight and obese patients with knee osteoarthritis: is more better? Arthritis Care Res (Hoboken). 2018;70:1569\u201375. https:\/\/doi.org\/10.1002\/acr.23608.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"628_CR33","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1002\/ACR.22805","volume-title":"Is there a dose-response relationship between weight loss and symptom improvement in Persons with knee osteoarthritis? Arthritis care Res (Hoboken)","author":"I Atukorala","year":"2016","unstructured":"Atukorala I, Makovey J, Lawler L, Messier SP, Bennell K, Hunter DJ. Is there a dose-response relationship between weight loss and symptom improvement in Persons with knee osteoarthritis? Arthritis care Res (Hoboken). John Wiley and Sons Inc. 2016;68:1106\u201314. https:\/\/doi.org\/10.1002\/ACR.22805."},{"key":"628_CR34","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1093\/tbm\/iby037","volume-title":"Effect of intensive diet and exercise on self-efficacy in overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. Transl behav Med","author":"SL Mihalko","year":"2019","unstructured":"Mihalko SL, Cox P, Beavers DP, Miller GD, Nicklas BJ, Lyles M, et al. Effect of intensive diet and exercise on self-efficacy in overweight and obese adults with knee osteoarthritis: the IDEA randomized clinical trial. Transl behav Med. Oxford University Press; 2019;9:p. 227\u201335. https:\/\/doi.org\/10.1093\/tbm\/iby037."},{"key":"628_CR35","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1002\/ACR.24765","volume":"74","author":"SP Messier","year":"2022","unstructured":"Messier SP, Newman JJ, Scarlett MJ, Mihalko SL, Miller GD, Nicklas BJ, et al. Changes in body weight and knee pain in adults with knee osteoarthritis three-and-a-half years after completing diet and exercise interventions: follow-up study for a Single-Blind, Single-center, randomized controlled trial. Arthritis Care Res (Hoboken). 2022;74:607\u201316. https:\/\/doi.org\/10.1002\/ACR.24765.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"628_CR36","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/0091270010372625","volume":"51","author":"MA Karsdal","year":"2011","unstructured":"Karsdal MA, Henriksen K, Bay-Jensen AC, Molloy B, Arnold M, John MR, et al. Lessons learned from the development of oral calcitonin: the first tablet formulation of a protein in phase III clinical trials. J Clin Pharmacol. 2011;51:460\u201371. https:\/\/doi.org\/10.1177\/0091270010372625.","journal-title":"J Clin Pharmacol"},{"key":"628_CR37","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1002\/oby.23371","volume":"30","author":"AA Tahrani","year":"2022","unstructured":"Tahrani AA, Morton J. Benefits of weight loss of 10% or more in patients with overweight or obesity: a review. Obesity. 2022;30:802\u201340. https:\/\/doi.org\/10.1002\/oby.23371.","journal-title":"Obesity"},{"key":"628_CR38","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1056\/NEJMOA2403664","volume":"391","author":"H Bliddal","year":"2024","unstructured":"Bliddal H, Bays H, Czernichow S, Udd\u00e9n Hemmingsson J, Hjelmes\u00e6th J, Hoffmann Morville T, et al. Once-weekly semaglutide in Persons with obesity and knee osteoarthritis. N Engl J Med [Internet]. 2024;391:1573\u201383. https:\/\/doi.org\/10.1056\/NEJMOA2403664. cited 2025 Jan 23.","journal-title":"N Engl J Med"},{"key":"628_CR39","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/cells12040521","volume":"12","author":"YS Forte","year":"2023","unstructured":"Forte YS, Renovato-Martins M, Barja-Fidalgo C. Cellular and molecular mechanisms associating obesity to bone loss. Cells. 2023;12:521. https:\/\/doi.org\/10.3390\/cells12040521.","journal-title":"Cells"},{"key":"628_CR40","first-page":"73","volume":"120","author":"M Karsdal","year":"2019","unstructured":"Karsdal M, Henriksen K, Bay-Jensen A. Biochemical markers in osteoarthritis with lessons learned from osteoporosis. Clin Exp Rheumatol. 2019;120:73\u201387.","journal-title":"Clin Exp Rheumatol"},{"key":"628_CR41","doi-asserted-by":"publisher","unstructured":"Tobeiha M, Moghadasian MH, Amin N, Jafarnejad S. RANKL\/RANK\/OPG pathway: a mechanism involved in exercise-induced bone remodeling. Biomed Res Int. 2020;2020. https:\/\/doi.org\/10.1155\/2020\/6910312.","DOI":"10.1155\/2020\/6910312"},{"key":"628_CR42","doi-asserted-by":"publisher","unstructured":"Hou J, He C, He W, Yang M, Luo X, Li C. Obesity and Bone Health: a Complex link. Front Cell Dev Biol. 2020;8. https:\/\/doi.org\/10.3389\/fcell.2020.600181.","DOI":"10.3389\/fcell.2020.600181"},{"key":"628_CR43","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1146\/annurev.nutr.012809.104655","volume":"32","author":"SA Shapses","year":"2012","unstructured":"Shapses SA, Sukumar D. Bone metabolism in obesity and weight loss. Annu Rev Nutr. 2012;32:287\u2013309. https:\/\/doi.org\/10.1146\/annurev.nutr.012809.104655.","journal-title":"Annu Rev Nutr"},{"key":"628_CR44","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.joca.2014.04.002","volume-title":"The independent and combined effects of intensive weight loss and exercise training on bone mineral density in overweight and obese older adults with osteoarthritis. Osteoarthritis cartilage","author":"DP Beavers","year":"2014","unstructured":"Beavers DP, Beavers KM, Loeser RF, Walton NR, Lyles MF, Nicklas BJ, et al. The independent and combined effects of intensive weight loss and exercise training on bone mineral density in overweight and obese older adults with osteoarthritis. Osteoarthritis cartilage. Vol. 22. W.B. Saunders Ltd; 2014. pp. 726\u201333. https:\/\/doi.org\/10.1016\/j.joca.2014.04.002."},{"key":"628_CR45","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.clinbiochem.2011.01.001","volume":"44","author":"A-C Bay-Jensen","year":"2011","unstructured":"Bay-Jensen A-C, Liu Q, Byrjalsen I, Li Y, Wang J, Pedersen C, et al. Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM-Increased serum CIIM in subjects with severe radiographic osteoarthritis. Clin Biochem. 2011;44:423\u201329. https:\/\/doi.org\/10.1016\/j.clinbiochem.2011.01.001.","journal-title":"Clin Biochem"},{"key":"628_CR46","doi-asserted-by":"publisher","first-page":"547","DOI":"10.3109\/1354750X.2015.1105497","volume-title":"Synovitis biomarkers: ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis. Biomarkers","author":"C Kjelgaard-Petersen","year":"2015","unstructured":"Kjelgaard-Petersen C, Siebuhr AS, Christiansen T, Ladel C, Karsdal M, Bay-Jensen AC. Synovitis biomarkers: ex vivo characterization of three biomarkers for identification of inflammatory osteoarthritis. Biomarkers. Taylor and Francis Ltd; 2015;20:p. 547\u201356. https:\/\/doi.org\/10.3109\/1354750X.2015.1105497."},{"key":"628_CR47","doi-asserted-by":"publisher","first-page":"100379","DOI":"10.2139\/ssrn.4199937","volume":"5","author":"A-C Bay-Jensen","year":"2023","unstructured":"Bay-Jensen A-C, Karsdal M, Thudium C, Samuels J, Abramson SB, Attur MG. Pathological tissue formation and degradation biomarkers correlate with patient reported outcomes. Osteoarthr Cartil Open. 2023;5:100379. https:\/\/doi.org\/10.2139\/ssrn.4199937.","journal-title":"Osteoarthr Cartil Open"},{"key":"628_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13075-023-03253-X\/TABLES\/6","volume-title":"Association of biochemical markers with bone marrow lesion changes on imaging-data from the foundation for the National Institutes of Health osteoarthritis biomarkers Consortium. Arthritis Res Ther","author":"SP Yu","year":"2024","unstructured":"Yu SP, Deveza LA, Kraus VB, Karsdal M, Bay-Jensen AC, Collins JE, et al. Association of biochemical markers with bone marrow lesion changes on imaging-data from the foundation for the National Institutes of Health osteoarthritis biomarkers Consortium. Arthritis Res Ther. BioMed Central Ltd; 2024;26:p. 1\u201313. https:\/\/doi.org\/10.1186\/S13075-023-03253-X\/TABLES\/6."},{"key":"628_CR49","doi-asserted-by":"publisher","first-page":"28","DOI":"10.31138\/mjr.121224.wlc","volume":"36","author":"T Georgiev","year":"2025","unstructured":"Georgiev T, Kabakchieva P. Weight loss, but not at any cost: risks and challenges in patients with osteoarthritis. Mediterr J Rheumatol. 2025;36:28. https:\/\/doi.org\/10.31138\/mjr.121224.wlc.","journal-title":"Mediterr J Rheumatol"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-026-00628-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00628-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-026-00628-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T12:41:19Z","timestamp":1775565679000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s41927-026-00628-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,28]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["628"],"URL":"https:\/\/doi.org\/10.1186\/s41927-026-00628-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7453208\/v1","asserted-by":"object"}]},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,28]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is a post-hoc analysis of data from the CSMC trial with clinicaltrial.gov numbers (NCT00704847 and NCT00486434. No new data was generated in this post hoc analysis. The original clinical trial was a global study approved by the Institutional Review Boards in China, Poland, Romania, Denmark, Estonia, and the Czech Republic and adhered to the ethical principles outlined in the Declaration of Helsinki. All included patients consented to the use of serum and urine samples for studying joint tissue turnover biomarkers.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"ACBJ, KH, CST, PEF, and MAK are full-time employees and shareholders of Nordic Bioscience, a privately owned soluble biomarker company. KM is a full-time employee of Nordic Bioscience. AB is a full-time employee and shareholder of NBCD A\/S. No AI technologies were used to generate the data or the manuscript. The manuscript was edited for English language by a human editor.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}